Continuing Medical Education Information

Target Audience

This activity has been designed to meet the educational needs of dermatology, plastic surgery, ophthalmology, and otolaryngology resident physicians and physicians participating in facial plastic surgery, ocular plastic surgery, dermatological surgery, and cosmetic surgery fellowships.

Statement of Need

Advances in facial aesthetic products and procedures involving injectable neurotoxins and fillers have resulted in improved outcomes, leading to increasing patient expectations. For these reasons, physician education on these agents with regard to efficacy, dosing, safety, treatment of adverse events, and optimal technique based on individual facial anatomy is of the utmost importance. However, many physicians who desire to enter the field of aesthetic medicine do not receive adequate training to be able to meet patient demands in clinical practice.

This educational program, guided by experienced thought leaders in the field of facial aesthetics, was designed to increase and reinforce physician understanding of anatomy, proper patient evaluation to facilitate individualized treatment, optimal injection technique, and the best possible use of available agents to attain optimal patient outcomes and ensure patient safety and satisfaction.

Educational Objectives

Upon proper completion of this program, the participant should be able to:

Define and differentiate the onset, duration, dosing, and mechanism of action of injectable dermal fillers and neuromodulators
Compare the efficacy and safety of dermal fillers and neuromodulators
Identify individualized therapy based on anatomical assessment, muscle mass, and gender
Define the optimal injection techniques for injectable dermal fillers and neuromodulators

Accreditation and Credit Designation

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Paradigm Medical Communications, LLC designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physician should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by an educational grant from Medicis Pharmaceutical Corporation.

Release date: June 1, 2011

Last review date: March 16, 2011

Expiration date: May 31, 2012

Estimated time to complete activity: 2.5 hours

Instructions for Participation

To receive a CME certificate of participation, participants must:

Review the Continuing Medical Education Information and the entire contents of the DVD
Download, print and complete the evaluation form and posttest, and fax to 845-398-5108 or go to www.AestheticCare.org and complete the evaluation form and posttest online for this activity.
A certificate of participation will be issued 6 to 8 weeks following receipt of a completed activity evaluation form and a completed posttest with a score of 65% or better.

For additional questions regarding CME credit, please contact Paradigm Medical Communications, LLC�s CME department at 845-398-5100 x10.

Contact Us

If you have trouble accessing this activity, email a description of your computer (operating system, processor, memory) and the problem (including any screen messages), your phone number, and when you can be reached by telephone to: contactus@paradigmmc.com.

Faculty and Disclosures

In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in this activity.

Michael A C Kane, MD; New York, NY

Grant/Research Support: Coapt, Medicis, Revance; Retained Consultant: Allergan, Bioform, Medicis, Mentor, Q-Med, Sanofi-Aventis; Speakers Bureau: Allergan, Medicis, Q-Med, Sanofi-Aventis; Stockholder: Allergan, Medicis.

Corey S Maas, MD, FACS; San Francisco, CA

Grant/Research Support: Allergan, Medicis, Mentor; Retained Consultant: Allergan, Mentor; Speakers Bureau: Allergan, Bioform, Medicis; Stockholder: Bioform.

Mark G Rubin, MD; La Jolla, CA

Grant/Research Support: Medicis; Retained Consultant: Medicis; Stockholder: Medicis.

Shannon Quante, BSN, RN; Chicago, IL

Retained Consultant: Medical Education Advocates: Speakers Bureau: American Society of Plastic Surgical Nurses, Medical Education Advocates, Medicis.

Independent peer reviewer: Nothing to disclose.

No Paradigm staff member who was in a position to control or influence the content of this educational activity has a conflict of interest.

Resolution of Conflict of Interest

Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each continuing medical education activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes including independent peer review (as in this activity). All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with public interest, and compliant with all regulatory guidance and the ACCME�s Standards for Commercial Support of Continuing Medical Education.

This CME activity is distributed by Paradigm Medical Communications, LLC, Orangeburg, NY. All materials � 2011 Paradigm Medical Communications, LLC, except where noted, and may not be reproduced in whole or in part without the express written permission of Paradigm Medical Communications, LLC.

Signed statements of informed consent granting permission for publication have been obtained for all photographs in which an individual can be identified.

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Please Click here to view take the online CME Test and Evaluation (registration required)